DGAP-News: 4SC presents Phase I data on its histone deacetylase ...Ad-Hoc-News (Pressemitteilung), GermanyThe lead autoimmune compound, 4SC-101, has completed a Phase IIa trial in Rheumatoid Arthritis, and recently entered a Phase IIa trial in Morbus Crohn's. The lead oncology compound, 4SC-201, recently completed a Phase I trial in multiple cancer ... |